数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

股本结构

单位:万股
公告日期 2024-03-04 2023-11-15 2023-10-12 2023-08-08 2023-07-26 2023-08-11
证券总股本 493.25 405.03 333.58 33358.00 29019.57 24184.99
普通股本 493.25 405.03 333.58 33358.00 29019.57 24184.99
优先股 未披露 未披露 未披露 未披露 0.10 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2024-03-01 2023-11-10 2023-10-13 2023-08-04 2023-07-21 2023-06-30
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2024-03-04 493.25 未披露 定期报告 2024-03-01
2023-11-15 405.03 未披露 定期报告 2023-11-10
2023-10-12 333.58 未披露
更多>>
Following the Annual Meeting, on October 10, 2023, the Board approved the Reverse Stock Split at the ratio of 1-for-100.
2023-10-13
2023-08-08 33358.00 未披露 定期报告 2023-08-04
2023-07-26 29019.57 0.10 定期报告 2023-07-21
2023-08-11 24184.99 未披露 定期报告 2023-06-30
2023-05-22 2488.77 未披露 定期报告 2023-05-17
2023-05-22 2036.85 未披露
更多>>
From December 31, 2022 to March 31, 2023 Issuance of common stock from secondary offering, net Issuance of common stock and Pre-Funded Warrant from public offering, net Issuance of common stock from vesting of restricted stock Issuance of common stock upon Pre-Funded Warrant exercises Issuance of common stock upon Common Stock Warrant cashless exercises
2023-03-31
2023-03-31 2027.54 未披露 定期报告 2023-03-27
2023-02-16 1673.50 未披露
更多>>
Common stock offered 9,018,519 shares by the company
2023-02-17
2023-03-31 771.65 未披露
更多>>
From December 31, 2021 to December 31, 2022 Issuance of Series A convertible preferred stock Shares surrendered for income taxes Redemption of Series A redeemable convertible preferred stock Issuance of common stock from secondary offering, net of offering costs Reverse stock split rounding adjustment Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan
2022-12-31
2022-11-14 731.91 未披露 定期报告 2022-11-08
2022-10-12 705.09 未披露
更多>>
T2 Biosystems, Inc. announced that the Company’s board of directors (the “Board”) has approved a reverse stock split of its common stock at a ratio of 1 post-split share for every 50 pre-split shares.
2022-10-13
2022-08-16 35254.27 未披露 定期报告 2022-08-11
2022-08-16 19845.14 未披露
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common stock from secondary offering, net Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan
2022-06-30
2022-05-12 17172.51 未披露 定期报告 2022-05-09
2022-05-12 17141.29 未披露
更多>>
From December 31, 2021 to March 31, 2022 Issuance of common stock from vesting of restricted stock Surrender of shares due to tax withholding Issuance of common stock from secondary offering, net
2022-03-31
2022-03-23 17103.70 未披露 定期报告 2022-03-18
2022-03-23 16640.09 未披露
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary public offerings, net of offering costs of $0.8 million
2021-12-31
2021-11-04 16596.79 未披露
更多>>
From June 30, 2021 to September 30, 2021 Issuance of common stock from vesting of restricted stock and exercise of stock options
2021-09-30
2021-08-09 16584.57 未披露 定期报告 2021-08-06
2021-08-09 16576.38 未披露
更多>>
from March 31, 2021 to June 30, 2021 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary offering, net
2021-06-30
2021-05-13 15010.80 未披露 定期报告 2021-05-11
2021-05-13 14849.17 未披露
更多>>
From December 31, 2020 to March 31, 2021 Issuance of common stock from vesting of restricted stock and exercise of stock options
2021-03-31
2021-03-31 14849.17 未披露 定期报告 2021-03-26
2021-03-31 14807.90 未披露
更多>>
From December 31, 2019 to December 31, 2020 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary public offerings, net of offering costs of $3.0 million
2020-12-31
2020-11-05 14795.55 未披露 定期报告 2020-11-03
2020-11-05 14795.44 未披露
更多>>
From June 30, 2020 to September 30, 2020 Issuance of common stock from exercise of stock options Issuance of common stock from secondary offering,net
2020-09-30
2020-08-12 14794.93 未披露 定期报告 2020-08-06
2020-08-12 12846.13 未披露
更多>>
From March 31, 2020 to June 30, 2020 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary offering, net
2020-06-30
2020-06-26 11953.78 未披露 定期报告 2020-06-08
2020-05-11 11917.26 未披露
更多>>
From December 31, 2019 to March 31, 2020 Issuance of common stock from vesting of restricted stock Issuance of common stock from secondary offering, net
2020-03-31
2020-03-16 10075.29 未披露 定期报告 2020-03-13
2020-03-16 5065.15 未披露
更多>>
From December 31, 2018 to December 31, 2019 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary public offering, net of offering costs of $175 Shares issued in connection with purchase agreement
2019-12-31
2019-11-18 4667.92 未披露 定期报告 2019-11-14
2019-11-18 4667.87 未披露
更多>>
from June 30, 2019 to September 30, 2019 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary offering, net Shares issued in connection with Purchase Agreement
2019-09-30
2019-08-02 4453.56 未披露
更多>>
from March 31, 2019 to June 30,2019 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan
2019-06-30
2019-05-10 4433.92 未披露
更多>>
from December 31, 2018 to March 31, 2019 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan
2019-03-31
2019-03-14 4432.00 未披露 定期报告 2019-03-08
2019-03-14 4417.54 未披露
更多>>
from December 31, 2017 to December 31, 2018 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary public offering, net of offering costs of $218
2018-12-31
2018-11-01 4403.88 未披露 定期报告 2018-09-30
2018-08-02 4376.76 未披露 定期报告 2018-07-31
2018-08-02 4347.24 未披露 定期报告 2018-06-30
2018-05-08 3601.99 未披露 定期报告 2018-03-31
2018-03-19 3601.98 未披露 定期报告 2018-03-14
2018-03-19 3594.89 未披露
更多>>
from December 31, 2016 to December 31, 2017 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary public offering, net of offering costs of $252
2017-12-31
2017-11-03 3582.50 未披露 定期报告 2017-10-30
2017-11-03 3579.67 未披露 定期报告 2017-09-30
2017-08-04 3076.43 未披露 定期报告 2017-08-02
2017-08-04 3076.39 未披露 定期报告 2017-06-30
2017-05-08 3059.43 未披露 定期报告 2017-03-31
2017-03-15 3057.61 未披露 定期报告 2017-03-03
2017-03-15 3048.27 未披露
更多>>
from December 31, 2015 to December 31, 2016 Issuance of common stock from exercise of stock options and employee stock purchase plan Issuance of common stock for private investment
2016-12-31
2016-11-08 3043.13 未披露 定期报告 2016-09-30
2016-08-08 2436.47 未披露 定期报告 2016-06-30
2016-05-09 2428.45 未披露 定期报告 2016-05-05
2016-04-29 2428.17 未披露 定期报告 2016-04-20
2016-05-04 2428.31 未披露 定期报告 2016-03-31
2016-03-09 2424.89 未披露 定期报告 2016-03-04
2016-03-09 2417.54 未披露
更多>>
from December 31, 2014 to December 31, 2015 Issuance of common stock from secondary public offering, net of offering costs of $2,732 Issuance of common stock from exercise of stock options and employee stock purchase plan
2015-12-31
2015-11-04 2038.45 未披露 定期报告 2015-11-03
2015-11-04 2033.93 未披露 定期报告 2015-09-30
2015-09-01 2033.90 未披露 定期报告 2015-08-31
2015-08-05 2032.47 未披露 定期报告 2015-08-03
2015-08-05 2031.30 未披露 定期报告 2015-06-30
2015-05-06 2025.59 未披露 定期报告 2015-05-04
2015-04-30 2020.50 未披露 定期报告 2015-04-20
2015-05-06 2019.90 未披露 定期报告 2015-03-31
2015-03-04 2012.56 未披露 定期报告 2015-03-02
2015-03-04 2004.16 未披露
更多>>
from December 31, 2013 to October 31,2014 Accretion of Series A-1, A-2, B, C, D, and E redeemable convertible preferred stock to redemption value Conversion of redeemable convertible preferred stock into common stock Issuance of common stock upon net settlement of warrants to purchase redeemable convertible preferred stock Issuance of common stock from initial public offering, net of offering costs of $7,700 Exercise of stock options a 1-for-1.7 reverse stock split of our common stock effected on July 25, 2014;
2014-10-31
2014-11-05 2004.06 未披露 定期报告 2014-09-30
2014-08-07 1919.70 未披露
更多>>
a 1-for-1.7 reverse stock split of our common stock effected on July 25, 2014; the automatic conversion of all outstanding shares of our preferred stock into 12,516,298 shares of our common stock, which will occur upon the closing of this offering; the issuance of 68,700 shares of our common stock as a result of the net exercise of all outstanding warrants, which will occur upon the closing of this offering;
2014-08-07
2014-07-28 141.20 2127.77
更多>>
The Company effected a 1-for-1.7 reverse stock split of its issued and outstanding common stock on July 25, 2014.
2014-07-28
2014-07-16 247.11 2127.77 定期报告 2014-06-30
2014-07-02 240.04 2127.77 定期报告 2014-03-31
Following the Annual Meeting, on October 10, 2023, the Board approved the Reverse Stock Split at the ratio of 1-for-100.
From December 31, 2022 to March 31, 2023 Issuance of common stock from secondary offering, net Issuance of common stock and Pre-Funded Warrant from public offering, net Issuance of common stock from vesting of restricted stock Issuance of common stock upon Pre-Funded Warrant exercises Issuance of common stock upon Common Stock Warrant cashless exercises
Common stock offered 9,018,519 shares by the company
From December 31, 2021 to December 31, 2022 Issuance of Series A convertible preferred stock Shares surrendered for income taxes Redemption of Series A redeemable convertible preferred stock Issuance of common stock from secondary offering, net of offering costs Reverse stock split rounding adjustment Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan
T2 Biosystems, Inc. announced that the Company’s board of directors (the “Board”) has approved a reverse stock split of its common stock at a ratio of 1 post-split share for every 50 pre-split shares.
From March 31, 2022 to June 30, 2022 Issuance of common stock from secondary offering, net Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan
From December 31, 2021 to March 31, 2022 Issuance of common stock from vesting of restricted stock Surrender of shares due to tax withholding Issuance of common stock from secondary offering, net
From December 31, 2020 to December 31, 2021 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary public offerings, net of offering costs of $0.8 million
From June 30, 2021 to September 30, 2021 Issuance of common stock from vesting of restricted stock and exercise of stock options
from March 31, 2021 to June 30, 2021 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary offering, net
From December 31, 2020 to March 31, 2021 Issuance of common stock from vesting of restricted stock and exercise of stock options
From December 31, 2019 to December 31, 2020 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary public offerings, net of offering costs of $3.0 million
From June 30, 2020 to September 30, 2020 Issuance of common stock from exercise of stock options Issuance of common stock from secondary offering,net
From March 31, 2020 to June 30, 2020 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary offering, net
From December 31, 2019 to March 31, 2020 Issuance of common stock from vesting of restricted stock Issuance of common stock from secondary offering, net
From December 31, 2018 to December 31, 2019 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary public offering, net of offering costs of $175 Shares issued in connection with purchase agreement
from June 30, 2019 to September 30, 2019 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary offering, net Shares issued in connection with Purchase Agreement
from March 31, 2019 to June 30,2019 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan
from December 31, 2018 to March 31, 2019 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan
from December 31, 2017 to December 31, 2018 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary public offering, net of offering costs of $218
from December 31, 2016 to December 31, 2017 Issuance of common stock from vesting of restricted stock, exercise of stock options and employee stock purchase plan Issuance of common stock from secondary public offering, net of offering costs of $252
from December 31, 2015 to December 31, 2016 Issuance of common stock from exercise of stock options and employee stock purchase plan Issuance of common stock for private investment
from December 31, 2014 to December 31, 2015 Issuance of common stock from secondary public offering, net of offering costs of $2,732 Issuance of common stock from exercise of stock options and employee stock purchase plan
from December 31, 2013 to October 31,2014 Accretion of Series A-1, A-2, B, C, D, and E redeemable convertible preferred stock to redemption value Conversion of redeemable convertible preferred stock into common stock Issuance of common stock upon net settlement of warrants to purchase redeemable convertible preferred stock Issuance of common stock from initial public offering, net of offering costs of $7,700 Exercise of stock options a 1-for-1.7 reverse stock split of our common stock effected on July 25, 2014;
a 1-for-1.7 reverse stock split of our common stock effected on July 25, 2014; the automatic conversion of all outstanding shares of our preferred stock into 12,516,298 shares of our common stock, which will occur upon the closing of this offering; the issuance of 68,700 shares of our common stock as a result of the net exercise of all outstanding warrants, which will occur upon the closing of this offering;
The Company effected a 1-for-1.7 reverse stock split of its issued and outstanding common stock on July 25, 2014.